Tnf Pharmaceuticals, Stock Probability of Future Stock Price Finishing Over 24.58

TNFA Stock   1.27  0.02  1.55%   
TNF Pharmaceuticals,'s future price is the expected price of TNF Pharmaceuticals, instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of TNF Pharmaceuticals, performance during a given time horizon utilizing its historical volatility. Check out TNF Pharmaceuticals, Backtesting, TNF Pharmaceuticals, Valuation, TNF Pharmaceuticals, Correlation, TNF Pharmaceuticals, Hype Analysis, TNF Pharmaceuticals, Volatility, TNF Pharmaceuticals, History as well as TNF Pharmaceuticals, Performance.
For information on how to trade TNF Stock refer to our How to Trade TNF Stock guide.
  
Please specify TNF Pharmaceuticals,'s target price for which you would like TNF Pharmaceuticals, odds to be computed.

TNF Pharmaceuticals, Target Price Odds to finish over 24.58

The tendency of TNF Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over  24.58  or more in 90 days
 1.27 90 days 24.58 
close to zero percent
Based on a normal probability distribution, the odds of TNF Pharmaceuticals, to move over  24.58  or more in 90 days from now is close to zero percent (This TNF Pharmaceuticals, probability density function shows the probability of TNF Stock to fall within a particular range of prices over 90 days) . Probability of TNF Pharmaceuticals, price to stay between its current price of  1.27  and  24.58  at the end of the 90-day period is about 77.34 .
Given the investment horizon of 90 days TNF Pharmaceuticals, has a beta of -0.3. This usually implies as returns on the benchmark increase, returns on holding TNF Pharmaceuticals, are expected to decrease at a much lower rate. During a bear market, however, TNF Pharmaceuticals, is likely to outperform the market. Additionally TNF Pharmaceuticals, has an alpha of 0.2652, implying that it can generate a 0.27 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   TNF Pharmaceuticals, Price Density   
       Price  

Predictive Modules for TNF Pharmaceuticals,

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as TNF Pharmaceuticals,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.061.268.99
Details
Intrinsic
Valuation
LowRealHigh
0.061.148.87
Details
Naive
Forecast
LowNextHigh
0.021.218.94
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.041.262.57
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as TNF Pharmaceuticals,. Your research has to be compared to or analyzed against TNF Pharmaceuticals,'s peers to derive any actionable benefits. When done correctly, TNF Pharmaceuticals,'s competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in TNF Pharmaceuticals,.

TNF Pharmaceuticals, Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. TNF Pharmaceuticals, is not an exception. The market had few large corrections towards the TNF Pharmaceuticals,'s value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold TNF Pharmaceuticals,, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of TNF Pharmaceuticals, within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.27
β
Beta against Dow Jones-0.3
σ
Overall volatility
0.20
Ir
Information ratio 0.03

TNF Pharmaceuticals, Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of TNF Pharmaceuticals, for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for TNF Pharmaceuticals, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
TNF Pharmaceuticals, generated a negative expected return over the last 90 days
TNF Pharmaceuticals, has high historical volatility and very poor performance
TNF Pharmaceuticals, may become a speculative penny stock
TNF Pharmaceuticals, was previously known as MyMD Pharmaceuticals and was traded on NASDAQ Exchange under the symbol MYMD.
Net Loss for the year was (4 M) with profit before overhead, payroll, taxes, and interest of 0.
TNF Pharmaceuticals, generates negative cash flow from operations
TNF Pharmaceuticals, has a poor financial position based on the latest SEC disclosures
Latest headline from businesswire.com: TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in SarcopeniaFrailty Induced by GLP-1 Weight Loss Drugs

TNF Pharmaceuticals, Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of TNF Stock often depends not only on the future outlook of the current and potential TNF Pharmaceuticals,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TNF Pharmaceuticals,'s indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.5 M
Cash And Short Term Investments4.9 M

TNF Pharmaceuticals, Technical Analysis

TNF Pharmaceuticals,'s future price can be derived by breaking down and analyzing its technical indicators over time. TNF Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of TNF Pharmaceuticals,. In general, you should focus on analyzing TNF Stock price patterns and their correlations with different microeconomic environments and drivers.

TNF Pharmaceuticals, Predictive Forecast Models

TNF Pharmaceuticals,'s time-series forecasting models is one of many TNF Pharmaceuticals,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary TNF Pharmaceuticals,'s historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about TNF Pharmaceuticals,

Checking the ongoing alerts about TNF Pharmaceuticals, for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for TNF Pharmaceuticals, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
TNF Pharmaceuticals, generated a negative expected return over the last 90 days
TNF Pharmaceuticals, has high historical volatility and very poor performance
TNF Pharmaceuticals, may become a speculative penny stock
TNF Pharmaceuticals, was previously known as MyMD Pharmaceuticals and was traded on NASDAQ Exchange under the symbol MYMD.
Net Loss for the year was (4 M) with profit before overhead, payroll, taxes, and interest of 0.
TNF Pharmaceuticals, generates negative cash flow from operations
TNF Pharmaceuticals, has a poor financial position based on the latest SEC disclosures
Latest headline from businesswire.com: TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in SarcopeniaFrailty Induced by GLP-1 Weight Loss Drugs
When determining whether TNF Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TNF Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tnf Pharmaceuticals, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tnf Pharmaceuticals, Stock:
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TNF Pharmaceuticals,. If investors know TNF will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TNF Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.48)
Return On Assets
(0.32)
Return On Equity
(2.98)
The market value of TNF Pharmaceuticals, is measured differently than its book value, which is the value of TNF that is recorded on the company's balance sheet. Investors also form their own opinion of TNF Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is TNF Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TNF Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect TNF Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TNF Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if TNF Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TNF Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.